Akorn, Inc. (AKRX), a specialty pharmaceuticals maker, said it struck a five-year deal with Bioniche Pharma for the manufacturing and supply of two hospital injectable products. Financial terms were undisclosed.
As per the deal, Akorn will be responsible for the manufacturing and supply of the two pharmaceutical products, which are expected to be launched in the second half of 2008.
Arthur Przybyl, Akorn's president and chief executive officer stated, "We continue to seek contract pharmaceutical manufacturing opportunities in hospital injectables, ophthalmics and lyophilized products in order to expand this business."
AKRX is currently trading at $3.23, up $0.01 or 0.31%, on a volume of 8K shares.
For comments and feedback contact: editorial@rttnews.com
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.